Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01767324 · ClinicalTrials.gov registry record · NA
Site Selection for Intracutaneous Saline Delivery
A NA study, sponsored by FluGen.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01767324 is a NA study that has completed, run by FluGen. The registered enrollment target is 12 participants.
The verdict
NCT01767324, a NA study, has completed, sponsored by FluGen.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of this exploratory study is to select the optimal body site for intracutaneous delivery of 0.5 milliliters of saline from the FLUGEN 101.2 microneedle-based device.
Interventions
- DEVICE Injection to deltoid
- DEVICE Injection to forearm
- DEVICE Injection to thigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-12 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01767324
The ClinicalTrials.gov registry entry for NCT01767324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FluGen, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Injection to deltoid is the first listed.
NCT01767324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01767324 about?
NCT01767324 is a clinical study titled "Site Selection for Intracutaneous Saline Delivery". The goal of this exploratory study is to select the optimal body site for intracutaneous delivery of 0.5 milliliters of saline from the FLUGEN 101.2 microneedle-based device.
What is the current status of trial NCT01767324?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2012-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01767324?
The interventions under investigation include: Injection to deltoid (DEVICE), Injection to forearm (DEVICE), Injection to thigh (DEVICE).
Who is sponsoring clinical trial NCT01767324?
This trial is sponsored by FluGen, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.